{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:12:07Z","timestamp":1792293127944,"version":"4.4.0"},"reference-count":45,"publisher":"American Society of Hematology","issue":"14","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,10,4]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>North American ATLL has a distinct genomic landscape with a high frequency of prognostic epigenetic mutations, including EP300 mutations. ATLL samples with mutated EP300 have compromised p53 function and are selectively sensitive to decitabine treatment.<\/jats:p>","DOI":"10.1182\/blood-2018-01-824607","type":"journal-article","created":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T12:25:41Z","timestamp":1538655941000},"page":"1507-1518","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":83,"title":["North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies"],"prefix":"10.1182","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8419-1091","authenticated-orcid":false,"given":"Urvi A.","family":"Shah","sequence":"first","affiliation":[{"name":"Department of Oncology, Montefiore Medical Center, Bronx, NY;"},{"name":"Department of Cell Biology and"},{"name":"Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine Y.","family":"Chung","sequence":"additional","affiliation":[{"name":"Department of Cell Biology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orsi","family":"Giricz","sequence":"additional","affiliation":[{"name":"Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kith","family":"Pradhan","sequence":"additional","affiliation":[{"name":"Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Kataoka","sequence":"additional","affiliation":[{"name":"Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanisha","family":"Gordon-Mitchell","sequence":"additional","affiliation":[{"name":"Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4527-5505","authenticated-orcid":false,"given":"Tushar D.","family":"Bhagat","sequence":"additional","affiliation":[{"name":"Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Mai","sequence":"additional","affiliation":[{"name":"Department of Cell Biology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqiang","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Cell Biology and"},{"name":"Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Ishida","sequence":"additional","affiliation":[{"name":"Department of Cell Biology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav S.","family":"Choudhary","sequence":"additional","affiliation":[{"name":"Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7371-1696","authenticated-orcid":false,"given":"Ancy","family":"Joseph","sequence":"additional","affiliation":[{"name":"Division of Oncology, Washington University School of Medicine, St Louis, MO;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Rice","sequence":"additional","affiliation":[{"name":"Department of Pathology, Phelps Hospital, Northwell Health, Sleepy Hollow, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadege","family":"Gitego","sequence":"additional","affiliation":[{"name":"Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystall","family":"Parrish","sequence":"additional","affiliation":[{"name":"Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0908-770X","authenticated-orcid":false,"given":"Matthias","family":"Bartenstein","sequence":"additional","affiliation":[{"name":"Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Goel","sequence":"additional","affiliation":[{"name":"Department of Oncology, Montefiore Medical Center, Bronx, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Mantzaris","sequence":"additional","affiliation":[{"name":"Department of Oncology, Montefiore Medical Center, Bronx, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Shastri","sequence":"additional","affiliation":[{"name":"Department of Oncology, Montefiore Medical Center, Bronx, NY;"},{"name":"Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Derman","sequence":"additional","affiliation":[{"name":"Department of Oncology, Montefiore Medical Center, Bronx, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Binder","sequence":"additional","affiliation":[{"name":"Department of Oncology, Montefiore Medical Center, Bronx, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kira","family":"Gritsman","sequence":"additional","affiliation":[{"name":"Department of Oncology, Montefiore Medical Center, Bronx, NY;"},{"name":"Department of Cell Biology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Kornblum","sequence":"additional","affiliation":[{"name":"Department of Oncology, Montefiore Medical Center, Bronx, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira","family":"Braunschweig","sequence":"additional","affiliation":[{"name":"Department of Oncology, Montefiore Medical Center, Bronx, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chirag","family":"Bhagat","sequence":"additional","affiliation":[{"name":"Genoptix, Carlsbad, CA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Hall","sequence":"additional","affiliation":[{"name":"Genoptix, Carlsbad, CA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Graber","sequence":"additional","affiliation":[{"name":"Genoptix, Carlsbad, CA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Ratner","sequence":"additional","affiliation":[{"name":"Division of Oncology, Washington University School of Medicine, St Louis, MO;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Montefiore Medical Center, Bronx, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seishi","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Verma","sequence":"additional","affiliation":[{"name":"Department of Oncology, Montefiore Medical Center, Bronx, NY;"},{"name":"Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2281-422X","authenticated-orcid":false,"given":"B. Hilda","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Cell Biology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9323-8007","authenticated-orcid":false,"given":"Murali","family":"Janakiram","sequence":"additional","affiliation":[{"name":"Department of Oncology, Montefiore Medical Center, Bronx, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111911214154100_B1","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fmicb.2012.00388","article-title":"Epidemiological aspects and world distribution of HTLV-1 infection","volume":"3","author":"Gessain","year":"2012","journal-title":"Front Microbiol"},{"issue":"suppl 1","key":"2019111911214154100_B2","first-page":"373","article-title":"Epidemiology, clinical features, and outcome of HTLV-1 related adult T-cell leukemia-lymphoma in a prevalent area in the United States","volume":"130","author":"Malpica Castillo","year":"2017","journal-title":"Blood"},{"issue":"32","key":"2019111911214154100_B3","doi-asserted-by":"crossref","first-page":"51981","DOI":"10.18632\/oncotarget.10223","article-title":"Adult T-cell leukemia\/lymphoma in the Caribbean cohort is a distinct clinical entity with dismal response to conventional chemotherapy","volume":"7","author":"Zell","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"2019111911214154100_B4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/0956462416684461","article-title":"Adult T-cell leukemia\/lymphoma in South and Central America and the Caribbean: systematic search and review","volume":"28","author":"Oliveira","year":"2017","journal-title":"Int J STD AIDS"},{"issue":"9","key":"2019111911214154100_B5","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/j.1537-2995.2009.02223.x","article-title":"Adult T-cell leukemia\/lymphoma in the Middle East: first report of two cases from Lebanon","volume":"49","author":"Bitar","year":"2009","journal-title":"Transfusion"},{"issue":"5","key":"2019111911214154100_B6","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1080\/10428194.2017.1365862","article-title":"Diagnostic challenges of adult T-cell leukemia\/lymphoma in North America \u2013 a clinical, histological, and immunophenotypic correlation with a workflow proposal","volume":"59","author":"Licata","year":"2018","journal-title":"Leuk Lymphoma"},{"issue":"14","key":"2019111911214154100_B7","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1002\/cncr.25147","article-title":"A critical analysis of prognostic factors in North American patients with human T-cell lymphotropic virus type-1-associated adult T-cell leukemia\/lymphoma: a multicenter clinicopathologic experience and new prognostic score","volume":"116","author":"Phillips","year":"2010","journal-title":"Cancer"},{"issue":"24","key":"2019111911214154100_B8","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1182\/blood-2015-03-632489","article-title":"Treatment and survival among 1594 patients with ATL","volume":"126","author":"Katsuya","year":"2015","journal-title":"Blood"},{"issue":"9","key":"2019111911214154100_B9","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1200\/JCO.2015.63.5540","article-title":"Racial patterns of peripheral T-cell lymphoma incidence and survival in the United States","volume":"34","author":"Adams","year":"2016","journal-title":"J Clin Oncol"},{"issue":"10","key":"2019111911214154100_B10","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/j.1349-7006.2012.02373.x","article-title":"Increase in incidence of adult T-cell leukemia\/lymphoma in non-endemic areas of Japan and the United States","volume":"103","author":"Chihara","year":"2012","journal-title":"Cancer Sci"},{"issue":"3","key":"2019111911214154100_B11","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87)","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br J Haematol"},{"issue":"20","key":"2019111911214154100_B12","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"3","key":"2019111911214154100_B13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/ng.2538","article-title":"Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation","volume":"45","author":"Morris","year":"2013","journal-title":"Nat Genet"},{"issue":"6","key":"2019111911214154100_B14","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1038\/bcj.2014.44","article-title":"FAT1 expression and mutations in adult acute lymphoblastic leukemia","volume":"4","author":"Neumann","year":"2014","journal-title":"Blood Cancer J"},{"issue":"11","key":"2019111911214154100_B15","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ng.3415","article-title":"Integrated molecular analysis of adult T cell leukemia\/lymphoma","volume":"47","author":"Kataoka","year":"2015","journal-title":"Nat Genet"},{"issue":"1-2","key":"2019111911214154100_B16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ymgme.2016.06.013","article-title":"CBP\/p300 acetyltransferase activity in hematologic malignancies","volume":"119","author":"Dutta","year":"2016","journal-title":"Mol Genet Metab"},{"issue":"10","key":"2019111911214154100_B17","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1046\/j.1432-1327.2001.02226.x","article-title":"p300\/CBP\/p53 interaction and regulation of the p53 response","volume":"268","author":"Grossman","year":"2001","journal-title":"Eur J Biochem"},{"issue":"4","key":"2019111911214154100_B18","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.cell.2008.03.025","article-title":"Acetylation is indispensable for p53 activation","volume":"133","author":"Tang","year":"2008","journal-title":"Cell"},{"issue":"5220","key":"2019111911214154100_B19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1126\/science.7604283","article-title":"Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I","volume":"269","author":"Migone","year":"1995","journal-title":"Science"},{"issue":"3","key":"2019111911214154100_B20","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1172\/JCI118193","article-title":"Constitutive activation of different Jak tyrosine kinases in human T cell leukemia virus type 1 (HTLV-1) tax protein or virus-transformed cells","volume":"96","author":"Xu","year":"1995","journal-title":"J Clin Invest"},{"issue":"25","key":"2019111911214154100_B21","doi-asserted-by":"crossref","first-page":"13897","DOI":"10.1073\/pnas.94.25.13897","article-title":"Proliferation of adult T cell leukemia\/lymphoma cells is associated with the constitutive activation of JAK\/STAT proteins","volume":"94","author":"Takemoto","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2019111911214154100_B22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1182\/blood-2017-01-761874","article-title":"Prognostic relevance of integrated genetic profiling in adult T-cell leukemia\/lymphoma","volume":"131","author":"Kataoka","year":"2018","journal-title":"Blood"},{"issue":"1","key":"2019111911214154100_B23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1600-065X.2012.01110.x","article-title":"Regulation of NF-\u03baB by the CARD proteins","volume":"246","author":"Jiang","year":"2012","journal-title":"Immunol Rev"},{"issue":"1","key":"2019111911214154100_B24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1056\/NEJMc1111708","article-title":"TET2 and DNMT3A mutations in human T-cell lymphoma","volume":"366","author":"Couronn\u00e9","year":"2012","journal-title":"N Engl J Med"},{"issue":"2","key":"2019111911214154100_B25","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng.2873","article-title":"Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas","volume":"46","author":"Palomero","year":"2014","journal-title":"Nat Genet"},{"issue":"1","key":"2019111911214154100_B26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12943-016-0500-z","article-title":"Mutation of epigenetic regulators TET2 and MLL3 in patients with HTLV-I-induced acute adult T-cell leukemia [published correction appears in Mol Cancer. 2016;15:20]","volume":"15","author":"Yeh","year":"2016","journal-title":"Mol Cancer"},{"issue":"3","key":"2019111911214154100_B27","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/73536","article-title":"Mutations truncating the EP300 acetylase in human cancers","volume":"24","author":"Gayther","year":"2000","journal-title":"Nat Genet"},{"issue":"1","key":"2019111911214154100_B28","first-page":"1","article-title":"Somatic mutations of the CREBBP and EP300 genes affect response to histone deacetylase inhibition in malignant DLBCL clones","volume":"2","author":"Andersen","year":"2012","journal-title":"Leuk Res Rep"},{"issue":"7360","key":"2019111911214154100_B29","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma","volume":"476","author":"Morin","year":"2011","journal-title":"Nature"},{"issue":"10","key":"2019111911214154100_B30","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.1038\/bcj.2015.89","article-title":"Mutation of chromatin modifiers; an emerging hallmark of germinal center B-cell lymphomas","volume":"5","author":"Lunning","year":"2015","journal-title":"Blood Cancer J"},{"issue":"7325","key":"2019111911214154100_B31","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nature09586","article-title":"Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2","volume":"468","author":"Ko","year":"2010","journal-title":"Nature"},{"issue":"2","key":"2019111911214154100_B32","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.molcel.2016.12.013","article-title":"Acetylation enhances TET2 function in protecting against abnormal DNA methylation during oxidative stress","volume":"65","author":"Zhang","year":"2017","journal-title":"Mol Cell"},{"issue":"7337","key":"2019111911214154100_B33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nature09730","article-title":"Inactivating mutations of acetyltransferase genes in B-cell lymphoma","volume":"471","author":"Pasqualucci","year":"2011","journal-title":"Nature"},{"key":"2019111911214154100_B34","article-title":"Histone deacetylase inhibitors abolish HBZ protein expression and induce cell death in HTLV-1 related adult T-cell leukemia-lymphoma","author":"Toomey","year":"2017"},{"issue":"14","key":"2019111911214154100_B35","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1182\/blood-2015-08-662593","article-title":"Polycomb-dependent epigenetic landscape in adult T-cell leukemia","volume":"127","author":"Fujikawa","year":"2016","journal-title":"Blood"},{"issue":"9","key":"2019111911214154100_B36","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1158\/2159-8290.CD-13-0117","article-title":"Mechanism-based epigenetic chemosensitization therapy of diffuse large B-cell lymphoma","volume":"3","author":"Clozel","year":"2013","journal-title":"Cancer Discov"},{"issue":"17","key":"2019111911214154100_B37","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1200\/JCO.2005.11.353","article-title":"Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73","volume":"23","author":"van Doorn","year":"2005","journal-title":"J Clin Oncol"},{"issue":"18","key":"2019111911214154100_B38","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1182\/blood-2008-10-185660","article-title":"PDLIM2 suppresses human T-cell leukemia virus type I Tax-mediated tumorigenesis by targeting Tax into the nuclear matrix for proteasomal degradation","volume":"113","author":"Yan","year":"2009","journal-title":"Blood"},{"issue":"4","key":"2019111911214154100_B39","first-page":"1043","article-title":"Increasing methylation of the CDKN2A gene is associated with the progression of adult T-cell leukemia","volume":"60","author":"Nosaka","year":"2000","journal-title":"Cancer Res"},{"issue":"11","key":"2019111911214154100_B40","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1158\/1078-0432.CCR-10-2393","article-title":"Prognostic significance of p14ARF, p15INK4b, and p16INK4a inactivation in malignant peripheral nerve sheath tumors","volume":"17","author":"Endo","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"8","key":"2019111911214154100_B41","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/ijc.23749","article-title":"Promoter methylation of the bone morphogenetic protein-6 gene in association with adult T-cell leukemia","volume":"123","author":"Taniguchi","year":"2008","journal-title":"Int J Cancer"},{"issue":"1","key":"2019111911214154100_B42","doi-asserted-by":"crossref","first-page":"402","DOI":"10.2353\/ajpath.2010.090236","article-title":"Multi-step aberrant CpG island hyper-methylation is associated with the progression of adult T-cell leukemia\/lymphoma","volume":"176","author":"Sato","year":"2010","journal-title":"Am J Pathol"},{"issue":"1","key":"2019111911214154100_B43","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.leukres.2004.05.004","article-title":"Methylation analysis of the adenomatous polyposis coli (APC) gene in adult T-cell leukemia\/lymphoma","volume":"29","author":"Yang","year":"2005","journal-title":"Leuk Res"},{"issue":"3","key":"2019111911214154100_B44","doi-asserted-by":"crossref","first-page":"227","DOI":"10.15430\/JCP.2013.18.3.227","article-title":"Epigenetic therapies as a promising strategy for overcoming chemoresistance in epithelial ovarian cancer","volume":"18","author":"Suh","year":"2013","journal-title":"J Cancer Prev"},{"issue":"8","key":"2019111911214154100_B45","first-page":"3207","article-title":"Methylation mediated silencing of TMS1 in breast cancer and its potential contribution to docetaxel cytotoxicity","volume":"29","author":"Gordian","year":"2009","journal-title":"Anticancer Res"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/132\/14\/1507\/1407054\/blood824607.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/132\/14\/1507\/1407054\/blood824607.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T14:04:18Z","timestamp":1574172258000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/132\/14\/1507\/39348\/North-American-ATLL-has-a-distinct-mutational-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,4]]},"references-count":45,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2018,10,4]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2018-01-824607","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,4]]}}}